The DOI matches its Crossref record; 89 of the 90 references it cites were found in a registry or an index; none of the 86 sources its claims cite is checked for support yet.
Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies
Abstract
Aims/hypothesis We systematically reviewed and summarised prospective data relating diabetes status to changes in cognitive function over time.Methods Published reports of longitudinal studies that described assessment of cognitive function in people with diabetes were sought. Studies were included if they assessed cognitive function in participants with diabetes at the beginning and at follow-up. Studies were excluded if they had (1) a follow-up period of less than 1 year, (2) a rate of loss to follow-up in excess of 30%, or (3) described selected subgroups. Change in cognitive function was recorded as either the mean change in score and/or the proportion of individuals developing various degrees of change in cognitive function. A pooled estimate was calculated for the latter.Results Of 1,165 abstracts and titles initially identified, 25 articles met the inclusion and exclusion criteria. Individuals with diabetes had a 1.2- to 1.5-fold greater change over time in measures of cognitive function than those without diabetes. When assessed by the Mini-Mental State Exam and the Digit Symbol Span tests, a diagnosis of diabetes increased the odds of cognitive decline 1.2-fold (95% CI 1.05-1.4) and 1.7-fold (95% CI 1.3-2.3), respectively . The odds of future dementia increased 1.6-fold (95% CI 1.4-1.8).Conclusions/interpretation Compared to people without diabetes, people with diabetes have a greater rate of decline in cognitive function and a greater risk of cognitive decline. Cognitive dysfunction should therefore be added to the list of chronic complications of diabetes.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This systematic overview of 25 prospective observational studies found that people with diabetes have greater cognitive decline and a higher risk of dementia than people without diabetes. The authors conclude that cognitive dysfunction should be added to the list of chronic complications of diabetes.
Key findings
- Among 25 included articles covering more than 8,656 people with diabetes and follow-up periods of 2 to 18 years, diabetes was associated with a 1.2- to 1.5-fold greater change over time in measures of cognitive function.
- Pooled estimates showed increased odds of cognitive decline on the MMSE/3MS (OR 1.2, 95% CI 1.05–1.4) and DSS (OR 1.7, 95% CI 1.3–2.3), and a 1.6-fold higher risk of future all-cause dementia (95% CI 1.4–1.8).
- For dementia subtypes, risks ranged from 1.2 to 2.3 for Alzheimer’s disease and from 2.2 to 3.4 for vascular dementia.
- In continuous DSS analyses, three studies reported a decline of 1.3 to 1.4% per year in people with diabetes; overall this decline was up to 1.5 times greater than in people without diabetes.
Methods
- Systematic review of longitudinal/prospective observational studies; Medline, EMBASE, and PsycINFO were searched, along with expert contact and bibliography review. Of 1,165 abstracts/titles, 50 were fully reviewed and 25 met inclusion/exclusion criteria.
- Inclusion required baseline and follow-up cognitive assessment, diabetes or glucose tolerance status, and English-language reporting; exclusions were follow-up under 1 year, loss to follow-up over 30%, or selected subgroups.
- Data were abstracted on age, diabetes definition, participant numbers, follow-up length, cognitive tools, and outcomes; pooled inverse variance-weighted log risk ratios with 95% CIs were calculated, with heterogeneity assessed by the Q statistic using Review Manager 4.2.
Limitations
- The paper states possible publication bias, though it argues this is unlikely because many included studies were prospective cohorts examining many risk factors; it also states that MMSE/3MS may underestimate diabetes effects because it poorly detects attention and processing speed.
- The paper states that included studies differed in definitions of clinically meaningful decline, diabetes identification, age groups, cognitive tools, statistical adjustment, baseline cognitive impairment, and follow-up completeness (73–92%), and that there is no evidence to date that diabetes management affects the rate or nature of cognitive dysfunction.
- Evident from the text: only three studies explicitly reported that data were collected without examiner awareness of diabetes status, and some pooled estimates relied on few studies, such as the DSS estimate based on two studies.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
34 Not checked yet · 23 Own result · 6 Own interpretation · 4 Own method · 1 No basis given
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Individuals with diabetes had a 1.2- to 1.5-fold greater change over time in measures of cognitive function than those without diabetes.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The odds of future dementia increased 1.6-fold (95% CI 1.4 -1.8).”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The definitions of dementia used in the included studies are sufficiently comparable to be combined in the review.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When assessed by the Mini-Mental State Exam and the Digit Symbol Span tests, a diagnosis of diabetes increased the odds of cognitive decline 1.2-fold (95% CI 1.05 -1.4) and 1.7-fold (95% CI 1.3 -2.3), respectively.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The 25 remaining articles [46 -70] comprised data from more than 8,656 people with diabetes, with follow-up periods ranging from 2 to 18 years.”
What the sources say
- Not checked yetcites [46 -70]
plainn = 8,656- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When assessed by the Mini-Mental State Exam and the Digit Symbol Span tests, a diagnosis of diabetes increased the odds of cognitive decline 1.2-fold (95% CI 1.05 -1.4) and 1.7-fold (95% CI 1.3 -2.3), respectively.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“However, in contrast to the acute negative effect of hypoglycaemia on cognition, there is little evidence to support chronic cognitive impairment secondary to hypoglycaemia.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Compared to people without diabetes, people with diabetes were 1.2 times more likely to experience cognitive decline as measured by the MMSE/3MS (95% CI 1.0 -1.4) and 1.7 times more likely to experience cognitive decline as measured by the DSS (95% CI 1.3 -2.3).”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The cognitive assessment instruments used across the included studies measure cognitive decline in a comparable way.
None of the sources cited for this claim have been checked yet.
In the paper
“Table 2 lists the six studies that reported time-related changes as a continuous variable using either the MMSE or 3MS score in individuals with and without a history of diabetes [49, 51, 52, 54, 65, 69].”
What the sources say
- Not checked yetcites [49] Wu JH, Haan MN, Liang J, Ghosh D, Gonzalez HM, Herman WH (2003) Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study. Ann Epidemiol 13:369–376 source
- Not checked yetcites [51] Fontbonne A, Berr C, Ducimetiere P, Alperovitch A (2001) Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 24:366–370 source
- Not checked yetcites [52] Haan MN, Shemanski L, Jagust WJ, Manolio TA, Kuller L (1999) The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 282:40–46 source
- Not checked yetcites [54] Gregg EW, Yaffe K, Cauley JA et al (2000) Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 160:174–180 source
- Not checked yetcites [65] Hassing LB, Hofer SM, Nilsson SE et al (2004) Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study. Age Ageing 33:355–361 source
- Not checked yetcites [69] Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K (2004) Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 164:1327–1333 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In these studies, diabetes status predicted an odds ratio for cognitive decline that ranged from 0.7 to 4.4.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The cognitive assessment instruments used across the included studies measure cognitive decline in a comparable way.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Three studies reported a decline ranging from 1.3 to 1.4% per year in people with diabetes.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Probably not a substantial claim. 12
- It may state two separate claims as one. 17
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of 1,165 abstracts and titles initially identified, 25 articles met the inclusion and exclusion criteria.”
- Also stated in: § Search · p. 3 · plain
“The 25 remaining articles [46 -70] comprised data from more than 8,656 people with diabetes, with follow-up periods ranging from 2 to 18 years.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
- Also stated in: § Search · p. 3 · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of these citations, 50 met the inclusion criteria and were fully reviewed and analysed.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The 25 remaining articles [46 -70] comprised data from more than 8,656 people with diabetes, with follow-up periods ranging from 2 to 18 years.”
plainn = 8,656- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Table 3, and Figs. 1 and 2 list and display results from the six studies that used the MMSE or 3MS [47 -51, 54, 62, 69] and the two studies that used the DSS [51, 54] to classify participants into those who did and did not experience cognitive decline.”
What the sources say
- Not checked yetcites [47] Nguyen HT, Black SA, Ray LA, Espino DV, Markides KS (2002) Predictors of decline in MMSE scores among older Mexican Americans. J Gerontol A Biol Sci Med Sci 57:M181–M185 source
- Not checked yetcites [48] Wu JH, Haan MN, Liang J, Ghosh D, Gonzalez HM, Herman WH (2003) Impact of diabetes on cognitive function among older Latinos: a population-based cohort study. J Clin Epidemiol 56:686–693 source
- Not checked yetcites [49] Wu JH, Haan MN, Liang J, Ghosh D, Gonzalez HM, Herman WH (2003) Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study. Ann Epidemiol 13:369–376 source
- Not checked yetcites [50] Haan MN, Mungas DM, Gonzalez HM, Ortiz TA, Acharya A, Jagust WJ (2003) Prevalence of dementia in older Ltinos: the influence of type 2 diabetes mellitus, stroke and genetic factors. J Am Geriat Soc 51:169–177 source
- Not checked yetcites [51] Fontbonne A, Berr C, Ducimetiere P, Alperovitch A (2001) Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 24:366–370 source
- Not checked yetcites [54] Gregg EW, Yaffe K, Cauley JA et al (2000) Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 160:174–180 source
- Not checked yetcites [62] Stewart R, Prince M, Mann A (2003) Age, vascular risk, and cognitive decline in an older, British, African-Caribbean population. J Am Geriat Soc 51:1547–1553 source
- Not checked yetcites [69] Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K (2004) Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 164:1327–1333 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
In the paper
“However, one study reported an improvement in score of 1.2% in people with diabetes; nevertheless this improvement was approximately half of the improvement experienced by the non-diabetic participants [51].”
What the sources say
- Not checked yetcites [51] Fontbonne A, Berr C, Ducimetiere P, Alperovitch A (2001) Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 24:366–370 source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Four studies used the DSS as a continuous variable (Table 2) to assess cognitive function and three reported an adverse effect of diabetes on cognitive function over time.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Five of these studies reported that participants with diabetes had a higher risk of developing cognitive decline than those without diabetes; in three of these the lower limit of the 95% confidence interval exceeded 1 (i.e. it was statistically significant).”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: The definitions of dementia used in the included studies are sufficiently comparable to be combined in the review.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Seventeen studies divided the participants into two groups based on whether or not participants did or did not experience cognitive decline during follow-up.”
plainn = 17- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Eight studies reported a variety of other cognitive tests, most of them reporting greater or equal cognitive change for the diabetic participants (Table 1) [46, 49, 51, 58, 63, 66, 69, 70]. Some, but not all of the tests detected a significant difference between the groups with and without diabetes.”
What the sources say
- Not checked yetcites [46] Logroscino G, Kang JH, Grodstein F (2004) Prospective study of type 2 diabetes and cognitive decline in women aged 70–81 years. BMJ 328:548 source
- Not checked yetcites [49] Wu JH, Haan MN, Liang J, Ghosh D, Gonzalez HM, Herman WH (2003) Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study. Ann Epidemiol 13:369–376 source
- Not checked yetcites [51] Fontbonne A, Berr C, Ducimetiere P, Alperovitch A (2001) Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 24:366–370 source
- Not checked yetcites [58] Leibson CL, Rocca WA, Hanson VA et al (1997) Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol 145:301–308 source
- Not checked yetcites [63] Robertson-Tchabo EA, Arenberg D, Tobin JD, Plotz JB (1986) A longitudinal study of cognitive performance in noninsulin dependent (type II) diabetic men. Exp Gerontol 21:459–467 source
- Not checked yetcites [66] Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA (2004) Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61:661–666 source
- Not checked yetcites [69] Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K (2004) Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 164:1327–1333 source
- Not checked yetcites [70] Yaffe K, Blackwell T, Kanaya AM, Davidowitz BA, Barrett-Connor E, Krueger K (2004) Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63:658–663 source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In these studies, individuals with diabetes had a greater absolute annual decline in score than those without diabetes; however, the differences only achieved statistical significance in one study [70].”
What the sources say
- Not checked yetcites [70] Yaffe K, Blackwell T, Kanaya AM, Davidowitz BA, Barrett-Connor E, Krueger K (2004) Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63:658–663 source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The selected studies were analysed according to previously published methodological criteria [12] to determine if they reported: (1) a predetermined method for selection of the participants; (2) the definition of diabetes mellitus; (3) the definition of the outcome; (4) use of the same cognitive assessment instrument in the two groups; (5) that data were collected unaware of the diabetes status (b”
What the sources say
- Not checked yetcites [12] Horwitz RI, Feinstein AR (1979) Methodologic standards and contradictory results in case-control research. Am J Med 66:556–564 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Only three studies explicitly reported that data were collected without the examiner being aware of the diabetes status of the participant [46, 51, 62].”
What the sources say
- Not checked yetcites [46] Logroscino G, Kang JH, Grodstein F (2004) Prospective study of type 2 diabetes and cognitive decline in women aged 70–81 years. BMJ 328:548 source
- Not checked yetcites [51] Fontbonne A, Berr C, Ducimetiere P, Alperovitch A (2001) Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 24:366–370 source
- Not checked yetcites [62] Stewart R, Prince M, Mann A (2003) Age, vascular risk, and cognitive decline in an older, British, African-Caribbean population. J Am Geriat Soc 51:1547–1553 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Heterogeneity was assessed using the Q statistic [20].”
What the sources say
- Not checked yetcites [20] Laird NM, Mosteller F (1990) Some statistical methods for combining experimental results. Int J Technol Assess Health Care 6:5–30 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“The validity of the MMSE as a screening tool for detecting dementia has been extensively studied [17]; its ability to detect changes in cognitive function for non-demented individuals has been documented mainly in the elderly [18].”
What the sources say
- Not checked yetcites [17] Tombaugh TN, McIntyre NJ (1992) The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 40:922–935 source
- Not checked yetcites [18] Brayne C, Spiegelhalter DJ, Dufouil C et al (1999) Estimating the true extent of cognitive decline in the old. J Am Geriatr Soc 47:1283–1288 source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“ple with diabetes have a greater rate of decline in cognitive function and a greater risk of cognitive decline.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: The definitions of dementia used in the included studies are sufficiently comparable to be combined in the review.
- Rests on an assumption: The cognitive assessment instruments used across the included studies measure cognitive decline in a comparable way.
- Rests on an assumption: The included studies' participants with diabetes are representative of people with diabetes generally.
In the paper
“Compared to non-diabetic individuals, diabetes increased the risk of vascular dementia and Alzheimer ' s dementia 1.3 and 4.4-fold, respectively.”
What the sources say
- Not checked yetcites [72] Yamada M, Kasagi F, Sasaki H, Masunari N, Mimori Y, Suzuki G (2003) Association between dementia and midlife risk factors: the Radiation Effects Research Foundation Adult Health Study. J Am Geriat Soc 51:410–414 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Experimental studies in animal models and in humans without diabetes have shown that poor glucose regulation after a glucose challenge test was associated with poorer performance on a variety of cognitive tests, the effect being more pronounced in the older age group [81].”
What the sources say
- Not checked yetcites [81] Messier C (2004) Glucose improvement of memory: a review. Eur J Pharmacol 490:33–57 source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Another factor suggesting that the reports underestimated the effect of diabetes on cognitive decline is the fact that most of the studies did not include information on people who died or who were lost to follow-up, when follow-up success itself could well be linked to good cognitive function.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“These findings are supported by previous reviews of the available longitudinal studies [3, 4, 6].”
What the sources say
- Not checked yetcites [3] Allen KV, Frier BM, Strachan MW (2004) The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur J Pharmacol 490:169–175 source
- Not checked yetcites [4] Areosa Sastre A, Grimley Evans J (2005) Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementia. The Cochrane Library, Issue 2, http://www.cochrane.org/cochrane/revabstr/AB003804.htm
- Not checked yetcites [6] Stewart R, Liolitsa D (1999) Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 16:93–112 source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Indeed, a recent review of the effect of therapy concluded that no studies were appropriate for inclusion in meta analysis [4].”
What the sources say
- Not checked yetcites [4] Areosa Sastre A, Grimley Evans J (2005) Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementia. The Cochrane Library, Issue 2, http://www.cochrane.org/cochrane/revabstr/AB003804.htm
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“As these domains may be selectively impaired in people with diabetes the MMSE/3MS will underestimate the impact of diabetes on cognitive function [10].”
What the sources say
- Not checked yetcites [10] Strachan MW, Deary IJ, Ewing FM, Frier BM (1997) Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 20:438–445 source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The study is also limited by the differences in the studies included with respect to: (1) the definition of a clinically meaningful decline in cognitive function; (2) identification of people with and without diabetes; (3) age groups that were studied; (4) cognitive assessment tools employed; (5) degree of statistical adjustment for confounders; (6) degree of cognitive impairment permitted in stud”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In one study, this finding was only noted in young participants, while findings in older participants were consistent with the results from the other studies [62].”
What the sources say
- Not checked yetcites [62] Stewart R, Prince M, Mann A (2003) Age, vascular risk, and cognitive decline in an older, British, African-Caribbean population. J Am Geriat Soc 51:1547–1553 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“However, many of the studies analysed by us were prospective cohort studies, which examined many risk factors for cognitive decline, and not just diabetes. This makes it unlikely that a lack of an association with diabetes would lead to non-publication.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In the other study, this finding was only noted for women, and only in certain cognitive tests. The large confidence interval and wide variability of scores between tests reported in this study suggest that a larger sample size could possibly have altered the results [69].”
What the sources say
- Not checked yetcites [69] Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K (2004) Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 164:1327–1333 source
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper relies on this without support.
The definitions of dementia used in the included studies are sufficiently comparable to be combined in the review.
“The definition of dementia used in each study was accepted for this review.”
The paper relies on this without support.
The cognitive assessment instruments used across the included studies measure cognitive decline in a comparable way.
“Cognitive function was measured using a variety of simple cognitive tests [9, 13, 14].”
The paper relies on this without support.
The included studies' participants with diabetes are representative of people with diabetes generally.
“The 25 remaining articles [46 -70] comprised data from more than 8,656 people with diabetes, with follow-up periods ranging from 2 to 18 years.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Older adults with diabetes are at higher risk of cognitive decline and institutionalization (12,13).”
From 13. Older Adults: Standards of Care in Diabetes—2024 (2024) · cites this paper as [12]
Experimental — accuracy not yet measuredIn the citing paper
“Type 2 diabetes (T2D) has been demonstrated to be related to accelerated cognitive decline (3) and increased risk of dementia (4)”
From Type 2 Diabetes and Antidiabetic Medications in Relation to Dementia Diagnosis (2014) · cites this paper as [3]
In the citing paper
“Cross-sectional studies have shown an association between hyperglycemia and cognitive dysfunction62.”
From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [62]
In the citing paper
“Evidence for impairments in peripheral insulin signalling in patients with AD was presented more than 25 years ago, 138 and the incidence of AD is known to be increased in patients with metabolic impairments such as diabetes 139,140 ; fittingly, some cognitive domains have been consistently found to be affected in type 2 diabetes (eg, memory, psychomotor speed, executive function).113”
From Intranasal insulin (2021) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Total (95% CI) | 2723 | 10044 | 1.6 (1.4, 1.8) |”
Reported 10044 · recomputed 11497
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Measures of cognitive function · p. 5
“| Gregg et al [54] | 402 | 584 | 1.0 (0.8, 1.4) |”
§ Measures of cognitive function · p. 4
“| MMSE/3MS | [54] | 65 - 99 (F) | History | 6 | 402 | 5844 | ≥ 11.5% a | 1.0 (0.8 - 1.4) e |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Total (95% CI) | 2723 | 10044 | 1.6 (1.4, 1.8) |”
Reported 2723 · recomputed 3585
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53221.x · Cited by 25,553
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,012
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J., & Wouters, E. (2015) · Gerontology · doi:10.1159/000430949 · Cited by 19,852
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. J. (2014) · Gerontology · doi:10.1159/000362720 · Cited by 19,007
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
The Mini‐Mental State Examination: A Comprehensive Review
Tombaugh, T. N., & McIntyre, N. J. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb01992.x · Cited by 5,152
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
The Prevalence of Comorbid Depression in Adults With Diabetes
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1069 · Cited by 3,926
Cited by
Sorted by citations
Items 301–400 of 998
Bhutada, P., Mundhada, Y. R., Humane, V., Rahigude, A., Deshmukh, P. H., Latad, S., & Jain, K. S. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.01.009 · Cited by 43
“Diabetics exhibit reduced psychomotor efficiency, cognitive flexibility and rapid information-processing (Bonnefont-Rousselot, 2002; Cukierman et al., 2005; Rovet, 2000), and double the probability of developing Alzheimer's disease and dementias (Arvanitakis et al., 2004; Biessels et al., 2006).”
BackgroundMirza, Z., Kamal, M. A., buzenadah, A., Al-Qahtani, M., & Karim, S. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660154 · Cited by 42
Cai, R., Han, J., Sun, J. L., Huang, R., Tian, S., Shen, Y., Dong, X., Xia, W., & Wang, S. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00179 · Cited by 45
“Studies have suggested that T2DM patients suffer from mild cognitive impairment (MCI) (Cukierman et al., 2005; Cheng et al., 2012), a transitional stage between normal cognitive aging and dementia (Mariani et al., 2007).”
BackgroundAssociation between diabetic retinopathy and incident cognitive impairment
Gupta, P., Gan, A. T. L., Man, R. E. K., Fenwick, E., Sabanayagam, C., Mitchell, P., Cheung, C. Y., Cheung, N., Wong, T. Y., Cheng, C.-Y., et al. (2019) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2018-312807 · Cited by 42
Ascher‐Svanum, H., Chen, Y.-F., Hake, A. M., Kahle‐Wrobleski, K., Schuster, D., Kendall, D. M., & Heine, R. J. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.01.002 · Cited by 43
Diabetes, but Not Hypertension and Obesity, Is Associated with Postoperative Cognitive Dysfunction
Lachmann, G., Feinkohl, I., Borchers, F., Ottens, T. H., Nathoe, H. M., Sauër, A.-M. C., Dieleman, J. M., Radtke, F. M., van Dijk, D., Spies, C., et al. (2018) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000492962 · Cited by 40
Diabetes and brain damage: more (or less) than meets the eye?
Ryan, C. M. (2006) · Diabetologia · doi:10.1007/s00125-006-0392-3 · Cited by 40
“Although a number of studies have reported a somewhat greater risk of dementia among diabetic patients, these risks are also relatively small, and in the order of a 1.5-fold increased risk [ 33 , 34].”
BackgroundInfluentialInsulin Signaling in Sporadic Alzheimer’s Disease
Liao, F., & Xu, H. (2009) · Science Signaling · doi:10.1126/scisignal.274pe36 · Cited by 41
“Trommer, Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.”
BackgroundSchernthaner, G., Barnett, A. H., Patel, S., Hehnke, U., von Eynatten, M., & Woerle, H. J. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12321 · Cited by 40
“Glycaemic control may also be important for the maintenance of cognitive function in the elderly [20].”
BackgroundPrevalence of Cognitive and Functional Impairment in a Community Sample from São Paulo, Brazil
Hototian, S. R., Lopes, M. A., Azevedo, D., Tatsch, M., Bazzarella, M. C., Bustamante, S. E. Z., Litvoc, J., & Bottino, C. M. C. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000112554 · Cited by 40
“and apparently this variable was not investigated in the other studies mentioned in table 5 . In a recently published systematic review of the literature on cognitive decline, dementia and diabetes, the authors [”
BackgroundHjelm, C., Broström, A., Dahl, A., Johansson, B. E. A., Fredrikson, M. G., & Strömberg, A. (2013) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e318275543d · Cited by 42
Zhong, Y., Zhu, Y., He, T., Li, W., Yan, H., & Miao, Y. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.09.023 · Cited by 39
Rouch, I., Trombert, B., Picard-Kossovsky, M., Laurent, B., Celle, S., Assoumou, G. N., Roche, F., & Barthélemy, J. (2014) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2014.01.005 · Cited by 41
Lee, Y. J., Kang, H. M., Kim, N. K., Yang, J. Y., Noh, J. H., Ko, K. S., Rhee, B. D., & Kim, D. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.2.150 · Cited by 39
“6-fold greater risk of dementia compared to people without diabetes [21].”
Neurocognitive Changes and Their Neural Correlates in Patients with Type 2 Diabetes Mellitus
Lee, J. H., Choi, Y., Jun, C. S., Hong, Y. S., Cho, H. B., Kim, J. E., & Lyoo, I. K. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.2.112 · Cited by 43
Zhang, S., Xue, R., & Hu, R. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02078-2 · Cited by 41
Clinical Manifestations of Aural Fullness
Park, M. S., Lee, H. Y., Kang, H. M., Ryu, E. W., Lee, S. K., & Yeo, S. G. (2012) · Yonsei Medical Journal · doi:10.3349/ymj.2012.53.5.985 · Cited by 39
“985 pISSN: 0513-5796, eISSN: 1976-2437 Yonsei Med J 53(5):985-991, 2012”
Diabetes and life-long cognitive ability
Mõttus, R., Luciano, M., Starr, J. M., & Deary, I. J. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.06.032 · Cited by 42
Assessment of the Cognitive Status in Diabetes Mellitus
Shuba, N. (2012) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2012/4837.2649 · Cited by 37
“As compared to the people without diabetes, the people with diabetes had a greater risk of a cognitive decline [21], especially in the memory and the executive functions [22].”
Kuszewski, J. C., Wong, R. H. X., & Howe, P. R. C. (2017) · Nutrients · doi:10.3390/nu9050487 · Cited by 39
He, A., Zhang, Y., Yang, Y., Li, L., Feng, X., Wei, B. K., Zhu, D., Liu, Y., Wu, L., Zhang, L., et al. (2017) · Brain Research · doi:10.1016/j.brainres.2017.05.022 · Cited by 37
“Epidemiological and experimental studies have indicated that people with diabetes show an increased risk in developing cognitive deficits and dementia as getting old (Cukierman et al., 2005).”
Yang, X. Q., Chen, Y., Zhang, W., Zhang, Z., Yang, X., Wang, P., & Yuan, H. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s271160 · Cited by 37
Metabolic Syndrome: Is It Time to Add the Central Nervous System?
Rojas, M., Chávez-Castillo, M., Pírela, D., Parra, H., Nava, M., Chacín, M., Angarita, L., Áñez, R., Salazar, J. J., Ortíz, R., et al. (2021) · Nutrients · doi:10.3390/nu13072254 · Cited by 40
A Comprehensive Review of Intranasal Insulin and Its Effect on the Cognitive Function of Diabetics
Gaddam, M., Singh, A., Jain, N., Avanthika, C., Jhaveri, S., la Hoz, I. D., Sanka, S., & Goli, S. R. (2021) · Cureus · doi:10.7759/cureus.17219 · Cited by 38
“6-fold greater risk for the development of future dementia makes this relationship irrefutable [4,7].”
BackgroundImpact of dementia on caring for patients’ diabetes
Feil, D. G., Lukman, R., Simon, B. F., Walston, A., & Vickrey, B. G. (2011) · Aging & Mental Health · doi:10.1080/13607863.2011.569485 · Cited by 36
Diabetes and cognitive impairment: how to evaluate the cognitive status?
Pasquier, F. (2010) · Diabetes & Metabolism · doi:10.1016/s1262-3636(10)70475-4 · Cited by 38
Cortical thinning in type 2 diabetes mellitus and recovering effects of insulin therapy
Chen, Z., Sun, J., Yang, Y., Lou, X., Wang, Y., Wang, Y., & Ma, L. (2014) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2014.07.014 · Cited by 36
“Previous studies demonstrated that patients with type 1 and type 2 diabetes can suffer from cognitive impairment [1–3], and our previous study also indicated that type 2 diabetes could lead to subtle brain structural changes (gray and white matter atrophy in the right temporal lobe) in patients who are free from demen…”
BackgroundTargeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes
Bak, A. M., Egefjord, L., Gejl, M., Steffensen, C., Stecher, C. W., Smidt, K., Brock, B., & Rungby, J. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.600691 · Cited by 37
“This was verified by a systematic overview of prospective observational studies from 2005, which conclude that people with diabetes have a greater rate of decline in cognitive function and a greater risk of cognitive decline than those without diabetes [8].”
MethodThe older patient with heart failure: high risk for frailty and cognitive impairment
Harkness, K. I., Heckman, G. A., & McKelvie, R. S. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.49 · Cited by 37
Santiago, J. C. P., & Hallschmid, M. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.03.007 · Cited by 37
Low, S. K., Ng, T. P., Lim, C. L., Moh, A. M. C., Ang, S. F., Wang, J., Goh, K. S., Ang, K., Tang, W. E., Kwan, P. Y., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-59914-3 · Cited by 39
Diabetes and education in the elderly
Tessier, D., & Lassmann-Vague, V. (2007) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)80059-0 · Cited by 36
“5 fold greater cognitive decline change over time in cognitive functions than those without DM [11].”
BackgroundInsulin‐dependent diabetes mellitus in older adults: Current status and future prospects
Ikegami, H., Hiromine, Y., & Noso, S. (2022) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14414 · Cited by 47
The Synergistic Effects of HIV, Diabetes, and Aging on Cognition
Vance, D. E., Fazeli, P. L., Dodson, J. E., Ackerman, M. L., Talley, M. H., & Appel, S. J. (2014) · Journal of Neuroscience Nursing · doi:10.1097/jnn.0000000000000074 · Cited by 36
Chen, J.-M., Chang, C.-W., Chang, T., Hsu, C.-C., Horng, J., & Sheu, W. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088434 · Cited by 36
“It is now well recognized that people with diabetes have a greater decline in cognitive function and a higher risk of developing dementia [1], although some studies declared that the relation between diabetes and major types of dementia remains controversial [2].”
BackgroundChaves, Y. C., Genaro, K., Stern, C. A. J., Guaita, G. D. O., Crippa, J. A. S., da Cunha, J. M., & Zanoveli, J. M. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135020 · Cited by 35
Kirvalidze, M., Hodkinson, A., Storman, D., Fairchild, T. J., Bała, M. M., Beridze, G., Zuriaga, A., Brudasca, N. I., & Brini, S. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104551 · Cited by 38
Similar pattern of peripheral neuropathy in mouse models of type 1 diabetes and Alzheimer's disease
Jolivalt, C. G., Calcutt, N. A., & Masliah, E. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.032 · Cited by 34
“…and problem solving being more common in both ype 1 and type 2 diabetic subjects than in the general opulation (Ryan et al., 1985; Reaven et al., 1990; Ryan nd Williams, 1993; McCarthy et al., 2002; Desrocher and ovet, 2004; Cukierman et al., 2005; Manschot et al., 006; Biessels et al., 2008).”
Moreira, T. J., Cebers, G., Pickering, C., Östenson, C.-G., Efendić, S., & Liljequist, S. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.10.054 · Cited by 36
Association of bilateral oophorectomy with cognitive function in healthy, postmenopausal women
Kurita, K., Henderson, V. W., Gatz, M., St. John, J., Hodis, H. N., Karim, R., & Mack, W. J. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.04.033 · Cited by 42
Doroszkiewicz, J., Mroczko, J., Winkel, I., & Mroczko, B. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13175057 · Cited by 36
“A summary of prospective observational research showed that diabetes raises the risk of cognitive deterioration by a factor of 1.2 to 1.7 [36].”
BackgroundInfluentialCognitive Training Is Ineffective in Hypoxemic COPD: A Six-Month Randomized Controlled Trial
Incalzi, R. A., Corsonello, A., Trojano, L., Pedone, C., Acanfora, D., Spada, A., Izzo, O., & Rengo, F. (2008) · Rejuvenation Research · doi:10.1089/rej.2007.0607 · Cited by 34
“10 A comparable result was obtained in a smaller controlled trial based on single domain training of 390 well-functioning older adults.”
Effect of 8-hydroxyquinoline and derivatives on human neuroblastoma SH-SY5Y cells under high glucose
Suwanjang, W., Prachayasittikul, S., & Prachayasittikul, V. (2016) · PeerJ · doi:10.7717/peerj.2389 · Cited by 37
“Diabetic patients exhibit 76 cognitive impairment including damaged verbal memory, diminished mental speed and mental 77 flexibility (Cukierman et al., 2005).”
BackgroundCognitive decline in metabolic syndrome is linked to microstructural white matter abnormalities
Alfaro, F. J., Lioutas, V., Maldonado, D. P., Chung, C., Bedoya, F. J., Yoo, W., & Novak, V. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8292-z · Cited by 34
“T2DM, HTN and other cardiovascular risk factors that are components of MetS have been individually associated with worse cognitive performance [30, 31] and subsequent cognitive decline [32, 33] in prior studies.”
Diabetes, dysglycemia and cognitive dysfunction
Cukierman‐Yaffe, T. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2507 · Cited by 36
Hong, B., Bea, S., Ko, H. Y., Kim, W. J., Cho, Y. M., & Shin, J.-Y. (2024) · Annals of Internal Medicine · doi:10.7326/m23-3220 · Cited by 33
Cocoa Flavanols, Cerebral Blood Flow, Cognition, and Health: Going Forward
Dinges, D. F. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200606001-00019 · Cited by 33
“It is also associated with status of diabetes.(17) Among the elderly, DSST performance has been found to be positively associated with motor performance (especially gait),(18) suggesting the DSST can serve as a general index of neurobehavioral capability in those in their seventh to ninth decades.”
BackgroundAssociation of GA/HbA1c ratio and cognitive impairment in subjects with type 2 diabetes mellitus
Kinoshita, T., Shimoda, M., Sanada, J., Fushimi, Y., Hirata, Y., Irie, S., Tanabe, A., Obata, A., Kimura, T., Hirukawa, H., et al. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.08.008 · Cited by 33
Gu, J.-X., Cheng, X., Luo, X., Yang, X., Pang, Y., Zhang, X.-F., Zhang, Y.-Y., & Liu, Y. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2608-6 · Cited by 33
Ameliorative potential of phloridzin in type 2 diabetes-induced memory deficits in rats
Kamdi, S. P., Badwaik, H. R., Raval, A., Ajazuddin, M., & Nakhate, K. T. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174645 · Cited by 33
Lifestyle, glucose regulation and the cognitive effects of glucose load in middle-aged adults
Riby, L. M., McLaughlin, J., & Riby, D. M. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508971324 · Cited by 34
“Crucially, the inability to efficiently regulate glucose is the key factor in disorders such as diabetes, and associated cognitive impairment within such groups can be considered one of the chronic complications (15) .”
Severity of Type 2 Diabetes, Cognitive Function, and Self-Care
Gatlin, P. K., & Insel, K. C. (2014) · Biological Research For Nursing · doi:10.1177/1099800414557565 · Cited by 33
“In studies where the participants with T2DM had fewer comorbid conditions or less severe diabetes, results have shown a lack of an association between T2DM and cognitive performance (Allen et al., 2004; Cukierman et al., 2005).”
BackgroundDearborn, J. L., Knopman, D., Sharrett, A. R., Schneider, A. L. C., Jack Jr., C. R., Coker, L. H., Alonso, A., Selvin, E., Mosley, T. H., Wagenknecht, L. E., et al. (2014) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000362265 · Cited by 32
Tepper, S., Sivashensky, A. A., Shahar, D. R., Geva, D., & Cukierman‐Yaffe, T. (2018) · Nutrients · doi:10.3390/nu10060767 · Cited by 42
“Evidence from the last decade has shown that diabetes and dysglycemia are risk factors for unhealthy aging, including cognitive dysfunction [1], dementia [2,3], depression [4], and disability [5].”
BackgroundNeuroprotective Effect of Astragalus Polysacharin on Streptozotocin (STZ)-Induced Diabetic Rats
Zhang, G., Fang, H., Li, Y., Xu, J., Zhang, D., Sun, Y., Zhou, L., & Zhang, H. (2019) · Medical Science Monitor · doi:10.12659/msm.912213 · Cited by 33
“5 times higher than that of non-diabetic patients [17].”
BackgroundAlbuminuria as a risk factor for mild cognitive impairment and dementia—what is the evidence?
Bikbov, B. T., Soler, M. J., Pešić, V., Capasso, G., Unwin, R. J., Endres, M., Remuzzi, G., Perico, N., Gansevoort, R. T., Mattace-Raso, F. U. S., et al. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab261 · Cited by 32
“7-fold, depending on the examination tool used [55, 56].”
Serum leptin and cognitive function in people with Type 2 diabetes
Labad, J., Price, J. F., Strachan, M. W. J., Deary, I. J., Seckl, J. R., Sattar, N. A., & Reynolds, R. M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.02.026 · Cited by 32
“Both type 2 diabetes (Cukierman et al., 2005) and obesity (Wolf et al.”
BackgroundDiabetes, Edentulism, and Cognitive Decline: A 12-Year Prospective Analysis
Wu, B., Luo, H., Tan, C., Qi, X., Sloan, F. A., Kamer, A. R., Schwartz, M. D., Martinez, M., & Plassman, B. L. (2023) · Journal of Dental Research · doi:10.1177/00220345231155825 · Cited by 33
“Diabetes mellitus (DM) is one of the most commonly recognized risk factors for cognitive decline (Gispen and Biessels 2000; Cukierman et al. 2005; Baumgart et al. 2015).”
Antidiabetic Oral Treatment in Older People
Abbatecola, A. M., Paolisso, G., Corsonello, A., Bustacchini, S., & Lattanzio, F. (2009) · Drugs & Aging · doi:10.2165/11534660-000000000-00000 · Cited by 32
Diabetes mellitus and dementia - a systematic review and meta-analysis.
Li, J., Yh, S., Gong, Y. P., Yh, L., Liu, Y., & Cl, L. (2014) · PubMed · Cited by 32
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations
Galiero, R., Caturano, A., Vetrano, E., Monda, M., Marfella, R., Sardu, C., Salvatore, T., Rinaldi, L., & Sasso, F. C. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s390752 · Cited by 36
“123 Owing to the development of complications, T2DM is often a cause of disability, which greatly influences the patient’s quality of life.”
BackgroundFeinkohl, I., Sattar, N. A., Welsh, P. I., Reynolds, R. M., Deary, I. J., Strachan, M. W. J., Price, J. F., & on behalf of the Edinburgh Type 2 Diabetes Study (ET2DS) Investigators (2012) · PLoS ONE · doi:10.1371/journal.pone.0044569 · Cited by 30
“5-fold increased risk of developing dementia [1,2], a disorder involving progressive cognitive, behavioural and motor deficits.”
Lietzau, G., Nyström, T., Östenson, C., Darsalia, V., & Patrone, C. (2016) · Oncotarget · doi:10.18632/oncotarget.6823 · Cited by 30
“Patients with T2D are more prone to develop cognitive impairment, dementia and neurodegenerative diseases than healthy individuals [46-49], with consequent high medical and social costs, in addition to individual suffering.”
BackgroundDehydroepiandrosterone (DHEA) and its Sulphate (DHEAS) in Alzheimer’s Disease
Štrac, D. Š., Konjevod, M., Perković, M. N., Tudor, L., Erjavec, G. N., & Pivac, N. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200317092310 · Cited by 31
Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes
Feinkohl, I., Keller, M., Robertson, C. M., Morling, J. R., McLachlan, S., Frier, B. M., Deary, I. J., Strachan, M. W. J., & Price, J. F. (2015) · Diabetologia · doi:10.1007/s00125-015-3581-0 · Cited by 30
“People with type 2 diabetes are at greater risk of cognitive impairment in later life than their non-diabetic peers [1].”
BackgroundStrachan, M. W. J., Reynolds, R. M., Frier, B. M., Mitchell, R. J., & Price, J. F. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00963.x · Cited by 30
Morais, H., Chaves, Y. C., Waltrick, A. P. F., Jesus, C. H. A., Genaro, K., Crippa, J. A. S., da Cunha, J. M., & Zanoveli, J. M. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.06.006 · Cited by 32
Laughter modulates prorenin receptor gene expression in patients with type 2 diabetes
Hayashi, T., Urayama, O., Hori, M., Sakamoto, S., Nasir, U. M., Iwanaga, S., Hayashi, K., Suzuki, F., Kawai, K., & Murakami, K. (2007) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2007.01.010 · Cited by 30
“A decline of cognition in diabetic patients [15] and a novel specific role for the prorenin receptor in cognitive functions [16] have also been reported.”
BackgroundUmegaki, H., Kawamura, T., Mogi, N., Umemura, T., Kanai, A., & Sano, T. (2008) · Age and Ageing · doi:10.1093/ageing/afn051 · Cited by 30
Altschul, D., Starr, J. M., & Deary, I. J. (2018) · Diabetologia · doi:10.1007/s00125-018-4645-8 · Cited by 27
“In general, it is difficult to determine the direction of causality in the association between type 2 diabetes and cognitive decline, but the current literature suggests that having type 2 diabetes causes greater cognitive decline [11, 12, 19, 45, 46].”
BackgroundMimenza-Alvarado, A. J., Jiménez-Castillo, G. A., Yeverino-Castro, S. G., Barragán-Berlanga, A. J., Pérez‐Zepeda, M. U., Ávila‐Funes, J. A., & Aguilar-Navarro, S. G. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01827-x · Cited by 31
Haigh, J., New, L. E., & Filippi, B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.580879 · Cited by 30
Faulkner, K. M., Uchmanowicz, I., Lisiak, M., Cichoń, E., Cyrkot, T., & Szczepanowski, R. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.713386 · Cited by 30
Meng, J., Zhu, Y., Ma, H., Wang, X., & Zhao, Q. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114464 · Cited by 30
Mehan, S., Bhalla, S., Siddiqui, E. M., Sharma, N., Shandilya, A., & Khan, A. (2022) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s247153 · Cited by 29
de Wet, H., Levitt, N. S., & Tipping, B. (2007) · PubMed · Cited by 29
Liu, D., Zhang, H., Gu, W., & Zhang, M. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1605-4 · Cited by 28
Senda, J., Ito, K., KOTAKE, T., Kanamori, M., Kishimoto, H., Kadono, I., Suzuki, Y., Katsuno, M., Nishida, Y., Ishiguro, N., et al. (2015) · Stroke · doi:10.1161/strokeaha.115.010682 · Cited by 28
Branson, S., Boss, L., Padhye, N. S., Gee, N. R., & Trötscher, T. T. (2019) · Anthrozoös · doi:10.1080/08927936.2019.1569908 · Cited by 33
Li, C., Zhang, J., Qiu, M., Liu, K., Li, Y., Zuo, Z., Yin, X., Lai, Y., Fang, J., Tong, H., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.615048 · Cited by 27
“Patients with T2DM have a considerably high risk of developing cognitive dysfunction (Cukierman et al., 2005; Koekkoek et al., 2015).”
BackgroundGong, J., Harris, K., Hackett, M. L., Peters, S. A. E., Brodaty, H., Cooper, M. E., Hamet, P., Harrap, S. B., Mancia, G., MacMahon, S. W., et al. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14391 · Cited by 31
Hyperglycemia, Hypoglycemia and Dementia: Role of Mitochondria and Uncoupling Proteins
Cardoso, S., Correia, S. C., Santos, R. X., Carvalho, C., Candeias, E., Duarte, A. I., Plácido, A. I., Santos, M. S., & Moreira, P. I. (2013) · Current Molecular Medicine · doi:10.2174/1566524011313040010 · Cited by 31
Liu, D., Zhang, H., GU, W., Liu, Y., & Zhang, M. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.1958 · Cited by 28
Insulin deficiency results in reversible protein kinase A activation and tau phosphorylation
van der Harg, J. M., Eggels, L., Bangel, F. N., Ruigrok, S. R., Zwart, R., Hoozemans, J. J. M., la Fleur, S. E., & Scheper, W. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.04.005 · Cited by 28
Dorsemans, A.-C., d’Hellencourt, C. L., Aït-Arsa, I., Jestin, E., Meilhac, O., & Diotel, N. (2017) · Journal of Visualized Experiments · doi:10.3791/55203 · Cited by 40
Melin, E. O., Thunander, M., Landin‐Olsson, M., Hillman, M., & Thulesius, H. O. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1495-8 · Cited by 28
Cukierman‐Yaffe, T., Gerstein, H. C., Anderson, C. S., Zhao, F., Sleight, P., Hilbrich, L., Jackson, S. H., Yusuf, S., & Teo, K. K. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.12.005 · Cited by 28
Self-citationThe therapeutic potential of probucol and probucol analogues in neurodegenerative diseases
Sharif, A., Mamo, J. C. L., Lam, V., Al‐Salami, H., Mooranian, A., Watts, G. F., Clarnette, R., Luna, G., & Takechi, R. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00398-w · Cited by 29
“Numerous cross-sectional and longitudinal studies have unequivocally shown that the prevalence of dementia among patients with T2D significantly surpasses that of age-matched non-diabetics [92–94].”
Cai, R., Huang, R., Han, J., Sun, H., Sun, J. L., Xia, W., Tian, S., Dong, X., Shen, Y., & Wang, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-12515-z · Cited by 27
Cognitive health expectancies of cardiovascular risk factors for cognitive decline and dementia
Zheng, L., Matthews, F. E., & Anstey, K. J. (2020) · Age and Ageing · doi:10.1093/ageing/afaa111 · Cited by 26
Hypoglycaemia in type 2 diabetes exacerbates amyloid‐related proteins associated with dementia
Moin, A. S. M., Al‐Qaissi, A., Sathyapalan, T., Atkin, S. L., & Butler, A. E. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14220 · Cited by 27
“The risk of dementia in individuals with T2D is strikingly increased (50-150%) relative to the general population (3-6).”
BackgroundDu, Y.-H., Yang, R., Wang, Q., Wang, L., Liang, L., Zhu, L., Sun, Y., & Cai, M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.670220 · Cited by 27
Piątkowska‐Chmiel, I., Herbet, M., Gawrońska‐Grzywacz, M., Pawłowski, K., Ostrowska-Leśko, M., & Dudka, J. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06341-7 · Cited by 34
Yanagawa, M., Umegaki, H., Uno, T., Khookhor, O., Kawano, N., Maeno, H., Yamanouchi, K., & Sato, Y. (2011) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2011.00691.x · Cited by 29
Wysokiński, A., Zboralski, K., Orzechowska, A., Gałecki, P., Florkowski, A., & Talarowska, M. E. (2010) · Archives of Medical Science · doi:10.5114/aoms.2010.14268 · Cited by 27
“[15] suggested that cognitive disorders should be included in the group of chronic complications of diabetes.”
BackgroundChen, R., Zhao, X., Gu, Z., Gu, P.-L., Zhou, B., Zhu, Z.-H., Xu, L., Zou, Y.-F., & Jiang, X. (2013) · Endocrine · doi:10.1007/s12020-013-0041-9 · Cited by 27
“It is reported [3] that a diagnosis of diabetes increased the odds of cognitive decline 1.”
BackgroundRisk factors of dementia in North India: a case–control study
Tripathi, M., Vibha, D., Gupta, P. K., Bhatia, R., Srivastava, M. V. P., Vivekanandhan, S., Singh, M. B., Prasad, K., Dergalust, S., & Mendez, M. F. (2011) · Aging & Mental Health · doi:10.1080/13607863.2011.583632 · Cited by 28
“9) (Brayne et al, 1998 ) to a significant association in others (Cukierman, Gerstein, & Williamson, 2005 ).”
Bonilla, C., Lawlor, D. A., Ben‐Shlomo, Y., Ness, A., Gunnell, D., Ring, S. M., Smith, G. D., & Lewis, S. J. (2012) · BMC Medical Genetics · doi:10.1186/1471-2350-13-90 · Cited by 30
“Elevated glucose levels such as those present in hyperglycaemia and diabetes have also been associated with diminished cognitive function, accelerated cognitive decline and higher risks for developing dementia and Alzheimer’s disease in the elderly [12-14] although not all studies find this [15].”
BackgroundInsulin and IGF-I prevent brain atrophy and DNA loss in diabetes
Šerbedžija, P., Madl, J. E., & Ishii, D. N. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.063 · Cited by 26
Metadata
- Authors
- Cukierman, T., Gerstein, H. C., & Williamson, J. D.
- Affiliations
- Population Health Research Institute (CA)
- Wake Forest University Health Sciences (US)
- Corresponding author
- Cukierman, T.
- Venue
- Diabetologia
- Published
- 2005-11-08
- Volume
- 48
- Issue
- 12
- Pages
- 2460-2469
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2046949772
- Cited by
- 1,049
- References
- 90
- Citations by year
- 2026: 23 · 2025: 47 · 2024: 37 · 2023: 56 · 2022: 72 · 2021: 58 · 2020: 62 · 2019: 70 · 2018: 54 · 2017: 61 · 2016: 65 · 2015: 67 · 2014: 77 · 2013: 64 · 2012: 43
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- diabetes mellitus, cognitive decline, dementia, cognitive function, Mini-Mental State Examination, Digit Symbol Substitution Test, chronic complications of diabetes, longitudinal cohort
- MeSH terms
- Cognition, Cognition Disorders, Dementia, Diabetes Mellitus, Follow-Up Studies, Humans, Intelligence Tests, Longitudinal Studies, Neuropsychological Tests, Prospective Studies, Risk Factors, Odds Ratio, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
